Combining PSPC1 siRNA with olaparib promoted greater tumor regression than did PSPC1 siRNA alone (p = 0.211), olaparib alone (p < 0.0001), and control siRNA (p < 0.0001) (Figure 4C). The gene discussed is PSPC1; the disease is neoplasm.